PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

Zhang X.; Gosselin N. H.; Marier J.; Peyret T.; Ito T.; Imel E.; Carpenter T. O.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

【24h】

PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

机译：X连锁性低磷血症成人的人抗FGF23抗体（KRN23）和血清磷的药动学/药代动力学模型。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共1页
作者
Zhang X.; Gosselin N. H.; Marier J.; Peyret T.; Ito T.; Imel E.; Carpenter T. O.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA. [J] . Zhang X., Gosselin N. H., Marier J., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：X连锁性低磷血症成人的人抗FGF23抗体（KRN23）和血清磷的药动学/药代动力学模型。
2. POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA. [J] . Zhang X., Peyret T., Gosselin N. H., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：KRN23的种群药代动力学，KRN23是一种人类抗FGF23抗体，用于治疗X连锁低血血症的成人。
3. Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia [J] . Zhang Xiaoping, Peyret Thomas, Gosselin Nathalie H., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2016,第4期

机译：成人X连锁性低磷血症的人单克隆抗FGF23抗体（KRN23）的4个月内剂量递增及其随后12个月剂量滴定研究的人群药代动力学和药效学分析
4. Use of Cytochrome P450-Specific Parameters and Human Biomarker Data To Develop a Human Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Dermal Chlorpyrifos Exposure [C] . Corie A. Ellison, James B. Knaak, Robin McDougall, ACS national meeting . 2012

机译：使用细胞色素P450特定参数和人类生物标志物数据开发针对皮毒死Expo暴露的人体生理学药代动力学/药效学模型
5. Contextualizing the Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies Through Molecular Imaging and Mathematical Modeling [D] . Tang, Yu. 2021

机译：通过分子成像和数学建模来抑制治疗性抗体的药代动力学和药效学
6. Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia [O] . Xiaoping Zhang, Erik A. Imel, Mary D. Ruppe, -1

机译：人类单克隆抗FGF23抗体（KRN23）的药代动力学和药效学在第一个针对成人X连锁低磷血症的多重上升剂量试验中
7. Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia [O] . Zhang Xiaoping, Imel Erik A., Ruppe Mary D., 2016

机译：人类单克隆抗FGF23抗体（KRN23）的药代动力学和药效学在第一个针对成人X连锁低磷血症的多重上升剂量试验中
8. Population Pharmacokinetic Modeling Approach Shows that Serum Penicillin G Concentrations Are Below Inhibitory Concentrations by Two Weeks after Benzathine Penicillin G Injection in the Majority of Young Adults. [R] . Neely, M., Kaplan, E. L., Blumer, J. L., 2014

机译：群体药代动力学模型方法显示，在大多数青少年中注射苯甲西林青霉素G后，血清青霉素G浓度低于抑制浓度两周。

PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF HUMAN ANTI-FGF23 ANTIBODY (KRN23) AND SERUM PHOSPHORUS IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.

著录项

相似文献

相关主题

期刊订阅